AXIN1 and neoplasm: YTHDF2 was upregulated in lung adenocarcinoma and was found to degrade axis inhibition protein 1 (AXIN1), which encodes a negative regulator of the Wnt/β-catenin signaling, eventually leading to Wnt/β-catenin activation and tumor progression [55].